POLYMERASE SUBSTRATE DEPLETION - A NOVEL STRATEGY FOR INHIBITING THE REPLICATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS

被引：47

作者：

ICHIMURA, H

LEVY, JA

机构：

[1] UNIV CALIF SAN FRANCISCO,SCH MED,CANC RES INST,SAN FRANCISCO,CA 94143

[2] UNIV CALIF SAN FRANCISCO,SCH MED,DEPT MED,SAN FRANCISCO,CA 94143

来源：

VIROLOGY | 1995年 / 211卷 / 02期

关键词：

D O I：

10.1006/viro.1995.1437

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Mycophenolic acid (MPA), an inhibitor of inosine monophosphate dehydrogenase, shows strong anti-HIV activity in vitro in both human peripheral blood CD4(+) lymphocytes and macrophages, as well as established human cell lines. MPA shows its greatest antiviral effects during the early stages of HIV infection. By limiting the rate of de novo synthesis of guanosine nucleotides, this drug apparently blocks the activity of reverse transcriptase, which is required for the formation of the HIV DNA provirus. MPA provides a novel strategy for inhibiting the replication of HIV and should be considered in clinical trials Of antiviral therapies. (C) 1995 Academic Press, Inc.

引用

页码：554 / 560

页数：7

共 18 条

[1]

Allison A.C., Almquist J.L., Muller C.D., Eugui E.M., In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443, Transplant. Proc, 23, pp. 10-14, (1991)

[2]

Allison A.C., Eugui E.M., The design and development of an immunosuppressive drug, myco phenol ate mofetil, Springer Semin. Immunopathol, 14, pp. 353-380, (1993)

[3]

Castro B.A., Barnett S.W., Evans L.A., Moreau J., Odehouri K., Levy J.A., Biologic Heterogeneity of Human Immunodeficiency Virus Type 2 (HIV-2). Virology, 178, pp. 527-534, (1990)

[4]

Castro B.A., Weiss C.D., Wiviott L.D., Levy J.A., Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells, J. Clin. MicroBiol, 26, pp. 2371-2376, (1988)

[5]

Chen M.S., Oshana S.C., Inhibition of HIV reverse transcriptase by 2’, 3’-dideoxynucleoside triphosphates, Biochem. Pharmacol, 36, pp. 4361-4362, (1987)

[6]

Cheng-Mayer C., Weiss C., Seto D., Levy J.A., Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus, Proc. Natl. Acad. Sci. USA, 80, pp. 8575-8579, (1989)

[7]

Condra J.H., Emini E.A., Gotlib L., Graham D.E., Schfabach A.E., Wolfgang J.A., Colonno R.J., Sardoma V.V., Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse non-nucleoside inhibitors, Antimicrob. Agents Che Mother, 36, pp. 1441-1446, (1992)

[8]

Gao W.Y., Cara A., Gallo R.C., Lori F., Low levels of deoxynucleotides in peripheral blood lymphocytes: A strategy to inhibit human immunodeficiency virus type 1 replication, Proc. Natl. Acad. Sci. USA, 90, pp. 8925-8928, (1993)

[9]

Hoffman A.D., Banapour B., Levy J.-A., Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions, Virology, 147, pp. 326-335, (1985)

[10]

Homsy J., Meyer M., Tateno M., Clarkson S., Levy J.A., The Fc and not the CD4 receptor mediates antibody enhancement of HIV infection in human cells, Science, 244, pp. 1357-1360, (1989)

← 1 2 →